# Vista Gold Corp: financial statements, quarterly

VGZ · NYSE · CIK 783324 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/vgz.md) · [Financials](/companies/vgz/financials.md) · [Filings](/companies/vgz/filings.md) · [Insiders](/companies/vgz/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/vgz/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [0.0](/filings/0000783324-24-000080.md) | [0.0 d](/filings/0000783324-25-000008.md) | [0.0](/filings/0000783324-25-000028.md) | [0.0](/filings/0000783324-25-000044.md) | [0.0](/filings/0000783324-25-000055.md) | [0.0 d](/filings/0000783324-26-000009.md) | [0.0](/filings/0000783324-26-000025.md) | [0.0](/filings/0000783324-26-000036.md) | [0.0](/filings/0000783324-25-000055.md) | [0.0 d](/filings/0000783324-26-000009.md) | [0.0](/filings/0000783324-26-000025.md) | [0.0](/filings/0000783324-26-000036.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | not reported | not reported | [(1.2)](/filings/0000783324-25-000028.md) | [15.5](/filings/0000783324-25-000044.md) | [(1.8)](/filings/0000783324-25-000055.md) | [(1.9) d](/filings/0000783324-26-000009.md) | [(2.9)](/filings/0000783324-26-000025.md) | [(2.5)](/filings/0000783324-26-000036.md) | [(2.1)](/filings/0000783324-25-000055.md) | [(1.8) d](/filings/0000783324-26-000009.md) | [(3.3)](/filings/0000783324-26-000025.md) | [(3.4)](/filings/0000783324-26-000036.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [(1.5)](/filings/0000783324-24-000080.md) | [(1.7) d](/filings/0000783324-25-000008.md) | [(1.1)](/filings/0000783324-25-000028.md) | [15.6](/filings/0000783324-25-000044.md) | [(1.6)](/filings/0000783324-25-000055.md) | [(1.7) d](/filings/0000783324-26-000009.md) | [(2.7)](/filings/0000783324-26-000025.md) | [(2.4)](/filings/0000783324-26-000036.md) | [(0.7)](/filings/0000783324-25-000055.md) | [(1.7) d](/filings/0000783324-26-000009.md) | [(3.1)](/filings/0000783324-26-000025.md) | [(3.0)](/filings/0000783324-26-000036.md) |
| Diluted EPS | $ per share | [(0.01)](/filings/0000783324-24-000080.md) | not reported | [(0.01)](/filings/0000783324-25-000028.md) | [0.12](/filings/0000783324-25-000044.md) | [(0.01)](/filings/0000783324-25-000055.md) | not reported | [(0.02)](/filings/0000783324-26-000025.md) | [(0.02)](/filings/0000783324-26-000036.md) | [(0.01)](/filings/0000783324-25-000055.md) | not reported | [(0.02)](/filings/0000783324-26-000025.md) | [(0.02)](/filings/0000783324-26-000036.md) |
| Basic EPS | $ per share | [(0.01)](/filings/0000783324-24-000080.md) | not reported | [(0.01)](/filings/0000783324-25-000028.md) | [0.13](/filings/0000783324-25-000044.md) | [(0.01)](/filings/0000783324-25-000055.md) | not reported | [(0.02)](/filings/0000783324-26-000025.md) | [(0.02)](/filings/0000783324-26-000036.md) | [(0.01)](/filings/0000783324-25-000055.md) | not reported | [(0.02)](/filings/0000783324-26-000025.md) | [(0.02)](/filings/0000783324-26-000036.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [4.8](/filings/0000783324-23-000056.md) | [6.1](/filings/0000783324-25-000008.md) | [11.9](/filings/0000783324-24-000048.md) | [20.2](/filings/0000783324-24-000068.md) | [19.0](/filings/0000783324-24-000080.md) | [17.0](/filings/0000783324-26-000009.md) | [15.0](/filings/0000783324-25-000028.md) | [13.2](/filings/0000783324-25-000044.md) | [13.7](/filings/0000783324-25-000055.md) | [13.6](/filings/0000783324-26-000036.md) | [52.7](/filings/0000783324-26-000025.md) | [49.5](/filings/0000783324-26-000036.md) |
| Current assets | $m | [5.1](/filings/0000783324-23-000056.md) | [6.5](/filings/0000783324-25-000008.md) | [12.4](/filings/0000783324-24-000048.md) | [20.6](/filings/0000783324-24-000068.md) | [19.2](/filings/0000783324-24-000080.md) | [17.5](/filings/0000783324-26-000009.md) | [15.4](/filings/0000783324-25-000028.md) | [13.5](/filings/0000783324-25-000044.md) | [13.9](/filings/0000783324-25-000055.md) | [14.1](/filings/0000783324-26-000036.md) | [53.2](/filings/0000783324-26-000025.md) | [50.0](/filings/0000783324-26-000036.md) |
| Total assets | $m | [7.5](/filings/0000783324-23-000056.md) | [8.9](/filings/0000783324-25-000008.md) | [15.3](/filings/0000783324-24-000048.md) | [21.0](/filings/0000783324-24-000068.md) | [20.1](/filings/0000783324-24-000080.md) | [19.0](/filings/0000783324-26-000009.md) | [17.0](/filings/0000783324-25-000028.md) | [15.2](/filings/0000783324-25-000044.md) | [15.9](/filings/0000783324-25-000055.md) | [16.3](/filings/0000783324-26-000036.md) | [55.3](/filings/0000783324-26-000025.md) | [52.3](/filings/0000783324-26-000036.md) |
| Current liabilities | $m | [0.9](/filings/0000783324-23-000056.md) | [0.9](/filings/0000783324-25-000008.md) | [1.2](/filings/0000783324-24-000048.md) | [0.8](/filings/0000783324-24-000068.md) | [1.1](/filings/0000783324-24-000080.md) | [1.0](/filings/0000783324-26-000009.md) | [1.4](/filings/0000783324-25-000028.md) | [1.2](/filings/0000783324-25-000044.md) | [1.1](/filings/0000783324-25-000055.md) | [1.1](/filings/0000783324-26-000036.md) | [1.8](/filings/0000783324-26-000025.md) | [1.5](/filings/0000783324-26-000036.md) |
| Total liabilities | $m | [1.0](/filings/0000783324-23-000056.md) | [4.0](/filings/0000783324-25-000008.md) | [11.2](/filings/0000783324-24-000048.md) | [0.8](/filings/0000783324-24-000068.md) | [1.1](/filings/0000783324-24-000080.md) | [1.1](/filings/0000783324-26-000009.md) | [1.4](/filings/0000783324-25-000028.md) | [1.3](/filings/0000783324-25-000044.md) | [1.2](/filings/0000783324-25-000055.md) | [1.2](/filings/0000783324-26-000036.md) | [1.9](/filings/0000783324-26-000025.md) | [1.6](/filings/0000783324-26-000036.md) |
| Shareholders' equity | $m | [6.5](/filings/0000783324-24-000080.md) | [5.0](/filings/0000783324-26-000009.md) | [4.1](/filings/0000783324-25-000044.md) | [20.1](/filings/0000783324-25-000055.md) | [19.0](/filings/0000783324-25-000055.md) | [17.9](/filings/0000783324-26-000036.md) | [15.6](/filings/0000783324-26-000036.md) | [13.9](/filings/0000783324-26-000036.md) | [14.7](/filings/0000783324-25-000055.md) | [15.1](/filings/0000783324-26-000036.md) | [53.4](/filings/0000783324-26-000036.md) | [50.8](/filings/0000783324-26-000036.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(1,095) d](/filings/0000783324-24-000080.md) | [(1,771) d](/filings/0000783324-25-000008.md) | [(1,318)](/filings/0000783324-25-000028.md) | [(1,377) d](/filings/0000783324-25-000044.md) | [(1,113) d](/filings/0000783324-25-000055.md) | [(1,927) d](/filings/0000783324-26-000009.md) | [(1,820)](/filings/0000783324-26-000025.md) | [(2,295) d](/filings/0000783324-26-000036.md) | [(526) d](/filings/0000783324-25-000055.md) | [(1,973) d](/filings/0000783324-26-000009.md) | [(2,200)](/filings/0000783324-26-000025.md) | [(2,521) d](/filings/0000783324-26-000036.md) |
| Capital expenditure | $k | not reported | [8.0 d](/filings/0000783324-25-000008.md) | [51.0](/filings/0000783324-25-000028.md) | [31.0 d](/filings/0000783324-25-000044.md) | [78.0 d](/filings/0000783324-25-000055.md) | [184 d](/filings/0000783324-26-000009.md) | [34.0](/filings/0000783324-26-000025.md) | [16.0 d](/filings/0000783324-26-000036.md) | [336 d](/filings/0000783324-25-000055.md) | [206 d](/filings/0000783324-26-000009.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [118](/filings/0000783324-23-000056.md) | [119](/filings/0000783324-24-000048.md) | [121](/filings/0000783324-24-000068.md) | [121](/filings/0000783324-24-000080.md) | [121](/filings/0000783324-25-000028.md) | [125](/filings/0000783324-25-000044.md) | [122](/filings/0000783324-25-000055.md) | [124](/filings/0000783324-26-000025.md) | [125](/filings/0000783324-26-000036.md) | [125](/filings/0000783324-25-000055.md) | [132](/filings/0000783324-26-000025.md) | [146](/filings/0000783324-26-000036.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 145,971,346 at 2026-07-24, from the cover of the [10-Q filed 2026-07-29](/filings/0000783324-26-000036.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:24 ET. No prices; not investment advice.